Carbon Monoxide Releasing Molecule Induces Endothelial Nitric Oxide Synthase Activation Through a Calcium and Phosphatidylinositol 3-kinase/Akt Mechanism
Overview
Pharmacology
Affiliations
The production of nitric oxide (NO) by endothelial NO synthase (eNOS) plays a major role in maintaining vascular homeostasis. This study elucidated the potential role of carbon monoxide (CO)-releasing molecules (CORMs) in NO production and explored the underlying mechanisms in endothelial cells. We observed that 25μM CORM-2 could increase NO production and stimulate an increase in the intracellular Ca level. Furthermore, ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetra acetic acid caused CORM-2-induced NO production, which was abolished by 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetraacetoxy-methyl ester (BAPTA-AM), indicating that intracellular Ca release plays a major role in eNOS activation. The inhibition of the IP3 receptor diminished the CORM-2-induced intracellular Ca increase and NO production. Furthermore, CORM-2 induced eNOS Ser phosphorylation and eNOS dimerization, but it did not alter eNOS expression. CORM-2 (25μM) also prolonged Akt phosphorylation, lasting for at least 12h. Pretreatment with phosphatidylinositol 3-kinase inhibitors (wortmannin or LY294002) inhibited the increases in NO production and phosphorylation but did not affect eNOS dimerization. CORM-2-induced eNOS Ser phosphorylation was intracellularly calcium-dependent, because pretreatment with an intracellular Ca chelator (BAPTA-AM) inhibited this process. Although CORM-2 increases intracellular reactive oxygen species (ROS), pretreatment with antioxidant enzyme catalase and N-acetyl-cysteine did not abolish the CORM-2-induced eNOS activity or phosphorylation, signifying that ROS is not involved in this activity. Hence, CORM-2 enhances eNOS activation through intracellular calcium release, Akt phosphorylation, and eNOS dimerization.
Rolnik A, Olas B, Szablinska-Piernik J, Lahuta L, Gromadzinski L, Majewski M Sci Rep. 2024; 14(1):25633.
PMID: 39465311 PMC: 11514185. DOI: 10.1038/s41598-024-76527-2.
Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?.
Arrigo E, Comita S, Pagliaro P, Penna C, Mancardi D Int J Mol Sci. 2023; 24(15).
PMID: 37569855 PMC: 10419417. DOI: 10.3390/ijms241512480.
The Triple Crown: NO, CO, and HS in cancer cell biology.
Oza P, Kashfi K Pharmacol Ther. 2023; 249:108502.
PMID: 37517510 PMC: 10529678. DOI: 10.1016/j.pharmthera.2023.108502.
Local delivery of gaseous signaling molecules for orthopedic disease therapy.
Sun J, Wang W, Hu X, Zhang X, Zhu C, Hu J J Nanobiotechnology. 2023; 21(1):58.
PMID: 36810201 PMC: 9942085. DOI: 10.1186/s12951-023-01813-6.
Wireless electrical stimulation at the nanoscale interface induces tumor vascular normalization.
Li C, Xiao C, Zhan L, Zhang Z, Xing J, Zhai J Bioact Mater. 2022; 18:399-408.
PMID: 35415302 PMC: 8965767. DOI: 10.1016/j.bioactmat.2022.03.027.